Get to know our CSO Sherly Mosessian, who’s featured as Partnology’s latest Biotech Leader Spotlight. Learn more about the journey that brought her to SOFIE and her thoughts on emerging technologies and how to positively impact your organization. #SOFIE#theranostics#womeninstem#womeninbio
Please join us in recognizing Chief Scientific Officer of SOFIE, Sherly Mosessian in this weeks Biotech Leader Spotlight Series! Check out our interview with Sherly to learn from her biomedical research and executive leadership expertise. Dr. Mosessian earned her bachelor’s degree in Biochemistry, followed by her Ph.D. from UCLA Department of Molecular and Medical Pharmacology, with publications in tumor signaling, molecular imaging targets and clinical trials of Positron Emission Tomography (PET) probes. She joined the SOFIE team in 2021 as the Vice President of Clinical and Regulatory Affairs leading the clinical development of FAPI diagnostic. She was promoted to Chief Scientific Officer in 2022. Prior to joining SOFIE, she served as a Chief Administrative Officer at UCLA and oversaw the establishment of a current Good Manufacturing Process (cGMP) facility in support of PET radiopharmaceutical production for research and clinical service. She successfully established a pathway at the UCLA Department of Pharmacology to translate PET imaging agents from bench to the clinic in a time and cost-efficient manner. In addition to her expertise in biomedical research, she has served in an executive leadership capacity in technology, having co-led the establishment of DGIT, the integrated information technology organization in support of the research and education mission of the UCLA School of Medicine. Dr. Mosessian is Armenian and having immigrated to the United States at a young age, values the importance of diversity/inclusion, seeking opportunities and having a strong work ethic. #biotechleaders #womeninbio #womeninscience #biotech #biotechnology